Clicky

Beijing Airdoc Technology Co Ltd(2251)

Description: Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions for medical institutions and consumer healthcare providers in Mainland China and internationally. It offers Airdoc-AIFUNDUS (1.0), an AI-based software as a medical device for auxiliary diagnosis of diabetic retinopathy; Airdoc-AIFUNDUS (2.0) for the auxiliary diagnosis of hypertensive retinopathy, retinal vein occlusion, and age-related macular degeneration; and Airdoc-AIFUNDUS (3.0) for the auxiliary diagnosis of pathological myopia, retinal detachment, glaucoma detection, cataracts detection, ICVD/ASCVD, gestational diabetic retinopathy, gestational hypertensive retinopathy, papilledema intracranial, hypertension retinopathy, and anemia. The company also provides health risk assessment solutions to detect risk indicators, such as various lesions and diseases, hyperthyroidism, graves ophthalmopathy, retinal vein occlusion, dementia, Parkinson's disease, atrial fibrillation, and arteriosclerosis in a range of healthcare environments, including health checkup centers, community clinics, insurance companies, optometry centers, and pharmacies. In addition, it offers hardware devices, including fundus cameras. The company was incorporated in 2015 and is headquartered in Beijing, China.


Keywords: Insurance Artificial Intelligence Disease Diabetes Organ Systems Ophthalmology Parkinson's Disease Hypertension Vision Dementia Anemia Glaucoma Diabetic Retinopathy Cataracts Retina Retinopathy Age Related Macular Degeneration Atrial Fibrillation Hardware Devices Medical Emergencies Fundus Photography Retinal Detachment Retinal Vein Occlusion Healthcare Environments Hyperthyroidism

Home Page: www.airdoc.com

Building 2
Beijing, 100089
China
Phone: 86 400 100 3999


Officers

Name Title
Mr. Dalei Zhang CEO & Exec. Chairman
Ms. Wenting Yang Joint Company Sec. & CFO
Dr. Yuzhong Chen Exec. Director
Mr. Hailong Chen Exec. Director
Mr. Fei Gao Exec. Director
Ms. Lai Shan So C.S., CGP Joint Company Sec.

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.7739
Price-to-Sales TTM: 14.8656
IPO Date:
Fiscal Year End: December
Full Time Employees: 340
Back to stocks